Login / Signup

The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology.

G SorceArmando StabileF PellegrinoE MazzoneA MatteiL AfferiS SerniA MinerviniM RoumiguièB MalavaudM ValerioA RakauskasG MarraP GonteroF PorpigliaH GuoJ ZhuangG GandagliaF MontorsiA Briganti
Published in: World journal of urology (2024)
Downgrading rates are highest when PCa is present in TBx only and, especially when the highest grade PCa is diagnosed by TBx cores only. Conversely, downgrading rates are lowest when PCa is identified with the same ISUP through both SBx and TBx. The presence of clinically significant disease at SBx + TBx may indicate a more reliable assessment of the disease at the time of biopsy potentially reducing the risk of downgrading at final pathology.
Keyphrases
  • prostate cancer
  • ultrasound guided
  • fine needle aspiration
  • cancer therapy
  • drug delivery